Corticosteroids Market Size Expected to Reach USD 6.91 Bn by 2033 [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Ottawa, April 18, 2024 (GLOBE NEWSWIRE) -- The global corticosteroids market size was valued at USD 4.71 billion in 2023 and is predicted to hit around USD 6.45 billion by 2032, a study published by Towards Healthcare a sister firm of Precedence Research. Report Highlights: Rheumatology application led the charge in 2023 with a 35% market share. Dermatology application is set to be the fastest-growing segment, boasting a 5.1% CAGR for healthier skin. Topical corticosteroids reign supreme, dominating the market with a 49% share in 2023. The Forum of International Respiratory Societies estimates that over 4.5 million people have lost their lives due to the current pandemic, primarily from respiratory issues. Corticosteroids have been widely employed in treating respiratory diseases during this crisis. Corticosteroids are a class of steroid hormones produced by the adrenal cortex, the outer portion of the adrenal glands located on top of each kidney. These hormones regulate
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly Shoots Higher: It's Time To Be Cautious [Seeking Alpha]Seeking Alpha
- Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at BMO Capital Markets from $900.00 to $1,001.00. They now have an "outperform" rating on the stock.MarketBeat
- Eli Lilly: Management Raises 2024 Guidance, Driven By GLP-1 Franchise [Seeking Alpha]Seeking Alpha
- ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at JPMorgan Chase & Co. from $850.00 to $900.00. They now have an "overweight" rating on the stock.MarketBeat
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/16/24 - Form 4
- LLY's page on the SEC website